When the gut shapes the brain
ADHD has been conceptualised for decades as a brain-based disorder — disrupted prefrontal cortex function, dopaminergic imbalances, and genetic variants affecting neurodevelopment. But a January 2026 paper from French neurologist Alexis Demas proposes a different starting point: what if some ADHD presentations originate not in the brain, but in the gut?
Demas argues that ADHD, autism spectrum conditions, and migraines can be usefully reframed as “neurointestinal syndromes” — conditions emerging from disrupted gut-brain-immune signalling rather than purely cortical pathology. The evidence: consistent abnormalities in gastrointestinal function across neurodivergent populations, including altered gut microbiota, increased intestinal permeability, dysregulated mucosal immunity, and low-grade systemic inflammation.
In children with ADHD, multiple studies report reduced microbial diversity and altered bacterial composition — specifically enrichment of Bacteroides, Bifidobacterium, and Clostridium species alongside depletion of short-chain fatty acid producers. These microbial shifts correlate with changes in metabolites affecting dopamine pathways, including phenylalanine and SCFAs like butyrate and propionate.
Children with autism display similar patterns: gastrointestinal symptoms, altered tryptophan metabolism, microbial profiles associated with immune dysregulation. The gut-brain axis operates through multiple channels — neural (vagal signalling), immune (cytokine release), endocrine (hormone modulation), and metabolic (microbial metabolites) — all active throughout development and capable of shaping long-term cognitive and emotional trajectories.
What makes migraines particularly interesting in this framework is that it’s traditionally classified as a primary neurological disorder. Yet migraineurs consistently show gut dysbiosis, increased intestinal permeability, and high comorbidity with inflammatory bowel conditions. The shared enteric substrate across ADHD, autism, and migraine suggests these conditions may represent different expressions of underlying gut-brain-immune disruption rather than entirely separate pathologies.
The paper doesn’t dismiss brain-centred models. It expands them, proposing that the gut is not a passive victim of brain dysfunction but an active architect of neurodevelopment, capable of modulating cortical connectivity through microbial metabolites, immune signalling, and vagal tone.
Interesting.
The ancient parasitic partnership we've lost, and perhaps miss
The hypothesis becomes evolutionary when Demas introduces helminths (parasitic worms) — intestinal parasites that coexisted with humans for hundreds of millennia. Soil-transmitted nematodes weren’t merely pathogens to be expelled. They shaped human physiology in fundamental ways, acting as immunoregulatory partners rather than simple enemies.
Helminths secrete molecules that dampen inflammatory responses, shifting host immunity toward regulatory T-cell and anti-inflammatory cytokine production. This isn’t immune suppression — it’s immune modulation, promoting tolerance while maintaining protective responses against genuine threats. The result: stabilised gut microbial ecosystems, prevented overgrowth of pro-inflammatory bacteria, supported SCFA-producing commensals.
The immunological effects extend beyond the gut. Helminth-induced activation of enzymes like indoleamine 2,3-dioxygenase diverts tryptophan metabolism into the kynurenine pathway, producing neuroactive metabolites including quinolinic acid and kynurenic acid. These metabolites affect serotonergic balance and glutamatergic signalling — influencing arousal, attention, mood regulation. The direction and magnitude vary depending on metabolite ratios, brain region, and developmental timing, but the principle holds: parasitic colonisation doesn’t just affect the gut, it modulates brain chemistry.
Vagal signalling provides another pathway. Helminth-derived products influence afferent vagal tone and autonomic nervous system regulation. Children with ADHD consistently show reduced vagal tone and impaired emotional regulation. The paper raises the possibility that early-life parasitic immune modulation might entrain long-term autonomic patterns, though this remains speculative (and is what makes this the evolutionary hypothesis research paper that it is).
Animal studies provide supporting evidence. Rodents infected with Toxocara canis or Trichinella spiralis exhibit increased anxiety-like behaviours and attention deficits for weeks or months after parasite clearance, demonstrating that even transient colonisation produces persistent neuromodulatory consequences. These models don’t directly map to human ADHD, but they establish plausibility for parasite-driven, lasting changes in brain function.
The evolutionary speculation: recurrent helminth exposure in ancestral environments may have acted as selective pressure shaping cognitive profiles characterised by hypervigilance, novelty-seeking, and rapid attention-switching. In pathogen-rich ecologies where threats were unpredictable and scanning behaviour valuable, such traits could have conferred advantages. The same traits in modern sedentary, structured environments present as disorder.
Demas is careful with this framing. And good. The paper explicitly states that it does not claim ADHD is a proven evolutionary adaptation. Demonstrating adaptation requires showing heritability, consistent fitness consequences, and genetic signatures of selection. Current ADHD evidence is incomplete on all three criteria. The evolutionary framing is presented as hypothesis-generating rather than established fact, and designed to push more gut-brain research.
What modern environments are revealing
This mismatch emerges in our post-industrial setting. Widespread deworming campaigns, improved sanitation, antibiotic overuse, and ultra-processed diets have eliminated helminths while destabilising gut microbial diversity. The ancient gut-immune architecture evolved expecting parasitic co-habitants no longer receives its historical regulatory signals.
Without “helminthic immunomodulation” (easy for you to say!), the gut-brain axis may operate more fragile, more inflammatory, and more vulnerable to dysbiosis (imbalance in the body’s microbial communities) associated with neurodevelopmental disruption. This doesn’t mean helminth loss is the sole cause of ADHD. It suggests helminth absence might be one contributor among many to changes in how neurodivergent phenotypes express in modern environments.
The epigenetic dimension adds transgenerational depth. Chronic helminth infections during critical developmental windows — prenatal, neonatal, early childhood — induce immune shifts and gut barrier remodelling that leave marks on gene expression. Affected genes include those governing intestinal mucosal architecture, cytokine production, serotonergic signalling, and stress axis regulation.
Evidence from rodent models shows early-life inflammation produces transgenerational effects on stress responsivity and gut physiology through DNA methylation addition (of on/off switch for a gene expression) and histone modifications (again, influencing gene activity without changing underlying DNA). In humans, maternal stress and inflammatory states are associated with DNA methylation changes in newborns with genes implicated in stress regulation, with downstream effects on temperament and psychopathology risk.
Direct demonstrations that helminth infections in humans produce heritable gut-brain epigenetic signatures are lacking. But the broader literature on inflammatory and microbial imprinting supports the plausibility. The “fragile gut” observed in ADHD may reflect not only individual traits but transgenerational architecture shaped by ancestral parasitic exposure.
From this perspective, neurodivergence becomes systemic legacy — an inherited balance between immunotolerance and vigilance, forged through millennia of host-parasite cohabitation and now mismatched with sanitised modernity.
Reframing ADHD for research purposes, without romanticising
Clinically, Demas emphasises integration rather than replacement. Stimulant medications and psychosocial interventions remain first-line and often highly effective. Their new framework is designed to motivate research into adjunctive strategies targeting the gut-brain axis for carefully phenotyped subgroups — those with documented gut dysfunction, inflammatory markers, or microbiome alterations.
Work on gut microbiome-based interventions in inflammatory bowel disease and other immune-mediated conditions demonstrates that restoring microbial resilience and barrier integrity can produce systemic benefits. Whether similar strategies meaningfully modulate ADHD symptoms in appropriate subgroups is an open question requiring rigorous randomised trials.
The heterogeneity matters. Many individuals with ADHD show no obvious gastrointestinal symptoms, no documented gut abnormalities, and respond robustly to standard dopaminergic medications. This doesn’t contradict the neurointestinal model — it highlights that ADHD encompasses multiple subtypes and pathways, and stress-tests the prevailing (only) brain-based disorder dogma. The gut-brain axis lens is particularly relevant for the subset with prominent gut symptoms, but is not necessarily universal.
This “helminth ADHD hypothesis” invites reconceptualisation of at least some neurodivergent presentations as whole-body ecological expressions rather than isolated brain disorders. The gut becomes not a mere secondary actor but a historical interface where microbes, parasites, and host tissues negotiated terms of coexistence — possibly inscribing some of the variability we now classify as neurodevelopmental conditions.
This reframing should not, and does not, minimise genuine impairment and subjective realities. Many individuals with ADHD experience significant functional difficulties, particularly in modern educational and economic systems. Evolutionary perspectives highlighting trade-offs and diversity must not be used to deny disability or discourage treatment. The goal is understanding mechanisms to improve interventions, not justifying under-treatment or conditional dismissal through adaptive narratives.
The framework also acknowledges confounding. Associations between gut dysfunction and ADHD are heavily influenced by diet, socioeconomic status, stress, sleep, medications, and broader environmental factors. Teasing apart causal relationships from correlations requires careful longitudinal work with appropriate controls.
But what the hypothesis offers is expanded possibility space. If some ADHD presentations emerge from disrupted gut-brain-immune signalling shaped by evolutionary mismatch, then therapeutic targets expand beyond neurotransmitters to include microbial ecology, barrier function, immune regulation, and vagal modulation. The challenge is identifying which individuals would benefit from which interventions — phenotyping the heterogeneity rather than assuming one mechanism fits all.
The migraine connection reinforces this integrative approach. If conditions as seemingly distinct as migraines and ADHD share gut-brain axis dysfunction, this suggests common mechanistic threads worth investigating across diagnostic categories. Perhaps the relevant distinction isn’t migraine versus ADHD, but gut-driven versus non-gut-driven presentations across multiple conditions.
For now, the helminth ADHD hypothesis remains exactly that: a hypothesis. What it accomplishes already though is yet another decent challenge of brain-centric orthodoxy, further motivating gut-brain research, and suggesting that understanding neurodevelopment may require understanding the whole organism in its prior (evolutionary) and present (ecological) contexts.
The gut is more than a barrier. It’s a historical stage where some foundational negotiations of immunity, cognition, and vulnerability were enacted — and where some answers to modern neurodevelopmental questions may still reside.
Update — May 2026
Four months on, the hypothesis remains a hypothesis — Demas was clear about that, and the evidentiary status has not shifted in any direction the field would call definitive. What has shifted is the wider context the gut-brain-immune argument now sits inside: a growing body of work indicating that ADHD and autism arise through partly separate trajectories interacting with environments that have changed faster than human biology has.
The Cambridge findings examined in genetic timing — when autism becomes visible is written in DNA demonstrated that timing of trait emergence is itself heritable, with distinct genetic pathways producing different developmental rhythms. Whatever role gut-brain signalling plays, it operates within that pre-existing variation rather than producing it.
The environmental side has accumulated too. Social media creating ADHD symptomatology and neurology examined a January 2026 Amsterdam study where pre-existing cognitive deficits failed to mediate the relationship between ADHD symptoms and problematic social media use — a null finding that fits the same evolutionary-mismatch scaffolding Demas leans on. And the ADHD as circadian disorder critique argued the parallel point — modern environments dysregulate multiple mammalian systems simultaneously.
Brain. Gut. Microbiome. Circadian. Cybernetic. Pick any one, and the others move with it.
Citations
Frontiers in Neuroscience — Rethinking ADHD as a neurointestinal syndrome: a gut-brain-parasite hypothesis (Demas, January 2026)
PLoS One — Gut microbiome in ADHD and its relation to neural reward anticipation (Aarts et al., 2017)
Annals of General Psychiatry — Systematic review of gut microbiota and ADHD (Alverina et al., 2021)
Journal of Headache and Pain — Gut-brain axis and migraine headache (Arzani et al., 2020)
Nature Reviews Gastroenterology & Hepatology — Role of short-chain fatty acids in microbiota-gut-brain communication (Dalile et al., 2019)
Nature Reviews Immunology — Regulation of immunity and allergy by helminth parasites (Maizels, 2020)
